BUCKINGHAM STRATEGIC WEALTH, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
BUCKINGHAM STRATEGIC WEALTH, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25,409
+33.3%
13,2340.0%0.00%
Q2 2023$19,057
+27.4%
13,2340.0%0.00%
Q1 2023$14,9540.0%13,2340.0%0.00%
Q4 2022$14,954
-32.0%
13,2340.0%0.00%
Q3 2022$22,000
+29.4%
13,2340.0%0.00%
Q2 2022$17,000
-19.0%
13,2340.0%0.00%
Q1 2022$21,000
-22.2%
13,2340.0%0.00%
-100.0%
Q4 2021$27,000
-35.7%
13,234
+23.3%
0.00%0.0%
Q3 2021$42,000
-17.6%
10,734
+7.3%
0.00%
-83.3%
Q1 2019$51,000
+50.0%
10,0000.0%0.01%
+20.0%
Q4 2018$34,000
-43.3%
10,0000.0%0.01%
-44.4%
Q3 2018$60,000
-6.2%
10,0000.0%0.01%
-10.0%
Q2 2018$64,000
+36.2%
10,0000.0%0.01%
+11.1%
Q1 2018$47,000
+42.4%
10,0000.0%0.01%
+28.6%
Q4 2017$33,000
-69.2%
10,000
-80.0%
0.01%
-72.0%
Q3 2017$107,000
-13.0%
50,0000.0%0.02%
-13.8%
Q2 2017$123,000
+7.0%
50,0000.0%0.03%
-12.1%
Q1 2017$115,00050,0000.03%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders